Optimistic half-year results AD 2022
PRESS RELEASE
The revenues of the Żywiec-based medical equipment manufacturer for the first half of this year are significantly higher than last year, an extremely successful year for the company. Famed should this year exceed the level of PLN 500 million in sales counted since 2013, when Famed Żywiec Sp. z o.o. was established, and approach the limit of PLN 100 million in annual revenues.
Sales of operating tables, hospital beds and other medical equipment in the first half of 2022 amounted to PLN 39.6 million. This result is 22 percent higher than the revenues of the same period last year. At that time they exceeded PLN 32 million.
— The main growth markets in which we recorded the largest increase over our plans turned out to be the domestic market, South Asia and Europe. In addition, an important factor in evaluating the results achieved is that cost increases did not exceed budget assumptions, which, thanks to higher sales and maintaining planned margins, resulted in higher sales profitability. EBITDA in the first six months is at a level exceeding last year’s result by 71 percent — says Pawel Tomala, vice president and chief financial officer of Famed Żywiec.
Between 2013 and 2021, the Żywiec-based manufacturer of technology and complex solutions for the medical sector received more than PLN 420 million from sales of its products. Exports of highly specialized medical equipment, currently conducted to 111 countries, accounted for 53 percent of revenues.
— We started from a really difficult position. The thorough restructuring of the company, carried out gradually, is bearing results. Since 2013, we have been recording steady revenue growth, and in the last four years it has been extremely dynamic, the average for this period is 15% year-on-year. Currently, we can say that Famed has returned to its proper place, one of the leaders in the medical industry not only in Poland, but also in Europe. The market situation is also favorable. Forecasts for the coming years look very attractive, and the data for the first half of the year confirm what we talked about after the end of this year’s Arab Health. Higher-than-anticipated sales are part of the anticipated demand impulse — comments Marek Suczyk, Famed’s vice president for marketing and sales.
— The company is in its best period and we have ambitions to use this potential for further dynamic growth. After Emerging Markets, the time will come for the markets of developed countries. Our aspirations are to reach the top of the global business in the segments of hospital beds and operating tables — Marek Suczyk concludes.